Highbridge Capital Management »

Theravance Biopharma shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9B 166k 11240.00
2023-09-30 $2.0M 227k 8.63
2023-03-31 $2.5M 230k 10.85
2022-12-31 $2.1M 186k 11.22
2021-06-30 $8.5M 588k 14.52
2017-09-30 $253k 7.4k 34.19
2015-12-31 $295k 18k 16.41
2015-03-31 $409k 24k 17.35
2014-12-31 $862k 58k 14.92